Retractable Technologies (NYSE:RVP) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP) in a research note issued to investors on Thursday morning. The firm issued a hold rating on the stock.

Retractable Technologies Trading Down 1.9 %

Retractable Technologies stock opened at $1.06 on Thursday. The business has a 50 day moving average of $1.19 and a 200-day moving average of $1.16. Retractable Technologies has a 1 year low of $0.95 and a 1 year high of $1.85. The company has a quick ratio of 6.41, a current ratio of 8.28 and a debt-to-equity ratio of 0.01.

Hedge Funds Weigh In On Retractable Technologies

A hedge fund recently raised its position in Retractable Technologies stock. WealthTrust Axiom LLC boosted its stake in Retractable Technologies, Inc. (NYSE:RVP) by 27.8% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 126,533 shares of the company’s stock after purchasing an additional 27,500 shares during the period. WealthTrust Axiom LLC owned about 0.42% of Retractable Technologies worth $151,000 at the end of the most recent reporting period. Institutional investors own 7.58% of the company’s stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.